gingivitis
Conditions
Interventions
This is a cross-over trial where all participants will undergo both treatments with a 30 day washout interval time. Allocation for each group will be by lottery. For the entry in the study, all partic
Group 2 = will be composed of 11 individuals who will receive oral hygiene instructions with a waterfloss irrigator adjunct standard manual toothbrushing and be instructed to maintain this protocol fo
Group 2 = will be composed of 10 individuals who will receive interproximal toothbrushing instructions to assist standard brushing and instructed to maintain this protocol for 60 days.
Data collection
Device
Sponsors
Faculdade de Odontologia da Universidade Federal de Minas Gerais
Faculdade de Odontologia da Universidade Federal de Minas Gerais
Eligibility
Age
25 Years to 65 Years
Inclusion criteria
Inclusion criteria: Individuals rehabilitated with mandibular implant-supported prothesis (4 to 5 implants) type "Branemark protocol"; from both genders; age between 25 and 65 years; agreeing to sign the Written Informed Consent
Exclusion criteria
Exclusion criteria: smokers or former-smokers; individuals diagnosed with diabetes and / or immunological diseases; pregnant or lactating women; systemic use of antibiotics or anti-inflammatory drugs in the last three months; individuals requiring the use of prophylactic antibiotics for treatment; individuals who regularly or have used any type of mouthwashes in the last three months; individuals who refuse to sign an Informed Consent; patients who during the study refuse, give up or have difficulty in practicing the proposed method of oral hygiene; patients who during the study need antibiotic therapy due to any reason.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Periimplantar bleeding evaluated through manual periodontal probing around the dental implants, being recorded in a dichotomous manner (presence / abscense) at 4 sites per implant (buccal, lingual, mesial, distal). Data will be evaluated in relation to the number / precent of affected sites and implants (level 1) aggregated within individuals (level 2) through hierarchical analysis. | — |
Secondary
| Measure | Time frame |
|---|---|
| Plaque index evaluated with disclosing agents, being recorded in a dichotomous manner (presence / abscense) at 4 sites per implant (buccal, lingual, mesial, distal). Data will be evaluated in relation to the number / precent of affected sites and implants (level 1) aggregated within individuals (level 2) through hierarchical analysis.;Bacterial count evaluated through real time PCR (q-PCR) for the total bacterial load and specific counts of C. rectus, P. gingivalis, T. forsythia, P.intermedia, T. denticola, A. actinomycetemcomitans e A. naeslundi. | — |
Countries
Brazil
Contacts
Public ContactLuís Cota
Faculdade de Odontologia da Universidade Federal de Minas Gerais
Outcome results
None listed